Search Results

54% of Top-Selling Medicare Drugs Rated as Low-Benefit, Study Finds.

• Authors : Weiser, Patricia

Subjects: *MEDICARE; HEALTH policy; EVALUATION of medical care

• Source: Formulary Watch. 4/27/2023, p1-1. 1p.

Record details

Public health.

Subjects: *CONFLICT of laws; *GOVERNMENT policy; *COMMERCIAL lawUNITED Kingdom

• Source: International Law Update. Jun99, Vol. 5, p65. 2p.

Record details

Spending on consumer advertising for top-selling prescription drugs in U.S. favors those with low added benefit.

• Source: Cancer Weekly; 2/21/2023, p839-839, 1p

Record details

Spending For Orphan Indications Among Top-Selling Orphan Drugs Approved To Treat Common Diseases.

• Authors : Kao-Ping Chua^1,2 ; Kimmel, Lauren E.³; Conti, Rena M.⁴

Subjects: *HEALTH insurance reimbursement; *COST analysis; CROSS-sectional method

• Source: Health Affairs. Mar2021, Vol. 40 Issue 3, p453-460. 8p.

Record details

Prescription Drugs to Your Door, Nearly as Ordering Pizza.

• Authors : SINGER, NATASHA; THOMAS, KATIE; Isaac, Mike

Subjects: *SELLING of drugs; *INTERNET pharmacies; *PUBLIC healthUNITED States

• Source: New York Times. 4/3/2019, Vol. 168 Issue 58286, pA1-A14. 2p.

Record details

Quality of Online Pharmacies and Websites Selling Prescription Drugs: A Systematic Review.

• Authors : Orizio, Grazia; Merla, Anna; Schulz, Peter J.

Subjects: INTERNET pharmacies; INTERNET; DRUG lawsGOOGLE (Web resource)

• Source: Journal of Medical Internet Research; Jul-Sep2011, Vol. 13 Issue 3, p29-29, 1p, 2 Diagrams

Record details

Using Arabic Tweets to Understand Drug Selling Behaviors.

• Authors : Alruwaili, Wesam; Protano, Bradley; Sirigiriraju, Tejasvi

Subjects: SELLING of drugs; DRUGS; SUPPORT vector machines

• Source: Procedia Computer Science; 2019, Vol. 164, p559-564, 6p

Record details

Healthcare Industry Report: Egypt.

Subjects: HEALTH care industry forecasting; PUBLIC health; SELLING of drugsEGYPTFREEDOM & Justice (Political party : Egypt)

• Source: Healthcare Industry Report: Egypt; Jul2012, Issue 2, preceding p1-14, 16p, 7 Charts, 11 Graphs

Record details

Consumer Marketing: Post COX-2s and SSRIs: Patient and public views.

Subjects: DRUG development; PHARMACEUTICAL industry; DRUG side effects

• Source: Journal of Medical Marketing; Jul2005, Vol. 5 Issue 3, p230-232, 3p

Record details

Global Health.

• Authors : McNEIL Jr., DONALD G.

Subjects: SELLING of drugs; ANTITUBERCULAR agents; PUBLIC health

• Source: New York Times. 7/2/2013, Vol. 162 Issue 56185, pD5-D5. 1/9p.

Record details